![](https://privacy-enhancing-tech-summit-eu.com/sites/default/files/styles/panopoly_image_square/public/speakers/posey_headshot_0.jpg?itok=woH8q3PO&c=f695aa5724d71132ca43d81f8092a8a0)
Dr. Avery Posey
Department of Pathology and Laboratory Medicine
University of Pennsyvania
![](https://privacy-enhancing-tech-summit-eu.com/sites/default/files/styles/panopoly_image_square/public/speakers/dr._francesco_galimi_global_product_general_manager_early_development_amgen_inc.jpg?itok=aexL6NjS&c=b2cd581ba38921df66f9cb04ed15fa10)
Dr. Francesco Galimi
Global Product General Manager, Early Development
Amgen Inc
![](https://privacy-enhancing-tech-summit-eu.com/sites/default/files/styles/panopoly_image_square/public/speakers/len_lichtenfeld.jpg?itok=VKO_Nv5D&c=3076c32270cd90e74c557a8d31d45802)
Dr. Leonard Lichtenfeld
Acting Chief Medical Officer
American Cancer Society
![](https://privacy-enhancing-tech-summit-eu.com/sites/default/files/styles/panopoly_image_square/public/speakers/stefan_scherer.png?itok=y71BeHep&c=e23fee2e4fcbf8953cff313d277b6083)
Dr. Stefan Scherer
Chief Medical Officer
Cellectis
![](https://privacy-enhancing-tech-summit-eu.com/sites/default/files/styles/panopoly_image_square/public/speakers/hanspeter_gerber.jpg?itok=glQvKbts&c=48ae036f72148cddfb8cb8b1a5154b7f)
Hans-Peter Gerber
CSO & SVP
3T Biosciences
![](https://privacy-enhancing-tech-summit-eu.com/sites/default/files/styles/panopoly_image_square/public/speakers/christina_coughlin_0.jpg?itok=oxv5d8yX&c=c0fc9aba52314a49d0911f90a3319a16)
Dr. Christina Coughlin
Chief Medical Officer & Executive Vice President
Tmunity
![](https://privacy-enhancing-tech-summit-eu.com/sites/default/files/styles/panopoly_image_square/public/speakers/john_mchutchinson_0.png?itok=wq9mWpT_&c=908ff7844e16b4fec03fda1af44d3a73)
Dr. John McHutchinson
Chief Scientific Officer & Head of Research and Development
Gilead
![](https://privacy-enhancing-tech-summit-eu.com/sites/default/files/styles/panopoly_image_square/public/speakers/alessandro_riva.png?itok=lXiRf1ek&c=c107cb7a3419192924d08ccd9a23a981)
Dr. Alessandro Riva
Executive Vice President, Oncology Therapeutics
Gilead